The Arab Drug Company

EGX-ADCI
Egyptian Stock Exchange
Pharmaceutical Preparations
Global Rank
#35111
Country Rank
#127
Market Cap
23.61 M
Price
3.93
Change (%)
0.89%
Volume
4,339

The Arab Drug Company (EGX-ADCI) Stock Split History

Date Split Ratio Multiple Cumulative multiple Type
07/27/2014 1.145:1 x1.145 x3.864375 Forward
12/30/2010 1.5:1 x1.5 x3.375 Forward
03/12/2009 1.5:1 x1.5 x2.25 Forward
03/22/2007 1.5:1 x1.5 x1.5 Forward

Frequently Asked Questions

  • How much would The Arab Drug Company stock be worth if it never split?
    If The Arab Drug Company (stock symbol: EGX-ADCI) had never undergone any stock splits, its price per share today would be approximately 15.21 USD. This calculation reflects the cumulative effect of all splits, including the most recent split (ratio: 1.145-for-1) that occurred on 07/27/2014.
  • The Arab Drug Company (stock symbol: EGX-ADCI) has undergone a total of four stock splits. The most recent split occurred on 07/27/2014. One share bought prior to the first split on 03/22/2007 would now equal 3.86 shares.
  • The Arab Drug Company (stock symbol: EGX-ADCI) has undergone four stock splits in its history. The most recent split, a 1.5-for-1 split, occurred on 07/27/2014. While future splits are not guaranteed, significant increases in stock price could prompt consideration for another split.

MarketCapWatch.com ranks all listed companies worldwide, providing unique insights into market capitalization across industries. As one of the most comprehensive ranking platforms, it covers companies of all sizes and sectors.

Ranking

Copyright © 2025. All rights reserved

Important Disclaimer: All content provided on this website, including hyperlinked pages, related applications, forums, blogs, social media accounts, and other platforms ("the Site"), is for general informational purposes only and sourced from third-party providers. We make no guarantees regarding the accuracy, completeness, or timeliness of the content.

None of the information presented constitutes financial, legal, or professional advice. Users should conduct their own research, evaluation, and verification before making any decisions. Investing and trading carry significant risks that may lead to substantial losses. Therefore, we strongly recommend consulting a qualified financial advisor before taking any action.